Chest Medicine (all articles)
CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk
9 Dec, 2020 | 08:23h | UTCCDC Releases New Ventilation Guidelines For Indoor Environments To Reduce Covid-19 Risk – Forbes
CDC Guideline: Ventilation
Related podcast: Air Handling Standards for Increasing the Safety of Indoor Spaces During the COVID-19 Pandemic – JAMA
Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen
9 Dec, 2020 | 08:25h | UTCCommentaries: Oxford COVID vaccine paper highlights lingering unknowns about results – Nature AND Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy – STAT AND Oxford–AstraZeneca COVID-19 vaccine efficacy – The Lancet AND Oxford COVID-19 vaccine is safe and protects against disease, first published results from phase 3 trials – The Lancet AND Expert reaction to a study on the results of phase 3 human trials of the Oxford/AZ COVID-19 vaccine – Science Media Centre
“COVID-19: when are you most infectious?” This commentary from the authors of a recent meta-analysis highlights the findings that infectiousness peaks within the first 5 days of symptom onset
10 Dec, 2020 | 08:38h | UTCCOVID-19: when are you most infectious? – The Conversation
Original study and commentaries: Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset
Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19
9 Dec, 2020 | 08:19h | UTCSummary for patients: Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection
If exposed to Covid-19, how long before you have symptoms? Median incubation is 5.1 days, and 97.5% of those who develop symptoms do so within 11.5 days of being exposed to the virus
8 Dec, 2020 | 08:06h | UTCIf Exposed To Covid-19 Coronavirus, How Long Before You Have Symptoms – Forbes
Opinion: “Get ready for vaccine false side effects”. When millions of people are vaccinated, naturally occurring health problems could be wrongly attributed to vaccines
8 Dec, 2020 | 07:55h | UTCGet Ready for False Side Effects – Science Translational Medicine
First-of-its-kind African trial tests common drugs to prevent severe COVID-19. “Could cheap, widely available drugs prevent patients with mild illness from becoming severely sick?”
8 Dec, 2020 | 07:46h | UTCFirst-of-its-kind African trial tests common drugs to prevent severe COVID-19 – Science
New CDC Guidance with 10 public health strategies to address high levels of community transmission of SARS-Cov-2, including universal use of face masks
7 Dec, 2020 | 01:10h | UTCCommentaries: Masks are critical to stopping coronavirus spread, even at home, CDC says – CNN AND CDC recommends ‘universal’ use of face masks to prevent COVID-19 spread – UPI
Commentary on Twitter
In most of the US, Covid transmission is at dangerously high levels. CDC released a new package of 10 key strategies needed to curb the spread, including universal masking and postponing travel. https://t.co/b0utHmygSI pic.twitter.com/HXjlo89WrR
— Dr. Tom Frieden (@DrTomFrieden) December 5, 2020
Meta-analysis: Respiratory function post-infection by COVID-19. Altered diffusion capacity, restrictive pattern, and obstructive pattern were found in 39%, 15% and 7% of patients, respectively
7 Dec, 2020 | 01:04h | UTC
Commentary on Twitter
Check out our recent systematic review in post-COVID-19 patients. Altered diffusion capacity, restrictive pattern and obstructive pattern were found in 39%, 15% and 7% of patients, respectively. @VilaroJordi @lvasconcello @RestoyAlsina @BufadorBufador https://t.co/PDHcUOCEbw
— Rodrigo Torres Castro (@klgorodtorres) November 25, 2020
Myocardial injury in severe COVID-19 is similar to traditional ARDS. It is a function of baseline comorbidities, advanced age, and multisystem organ dysfunction
7 Dec, 2020 | 00:59h | UTCCommentary: Myocardial Injury in Severe COVID-19 vs. ARDS – American College of Cardiology
Commentary on Twitter
About that “permanent heart damage” people associate with #COVID19…
Study published 11/13 found odds of heart damage was found to be *lower* in intubated C19 patients than in those w/ Acute Respiratory Distress Syndrome from non-Covid causes.https://t.co/rnRGFkfl0N pic.twitter.com/NN1f3DNrC7
— AJ Kay (@AJKayWriter) November 20, 2020
The UK has approved a COVID vaccine — but scientists still have many questions. One of them is if the vaccines will prevent the transmission of the disease
7 Dec, 2020 | 00:52h | UTCThe UK has approved a COVID vaccine — here’s what scientists now want to know – Nature
Study in Germany comparing regions with vs. without mask mandates concluded that 20 d after becoming mandatory, face masks reduced new Covid-19 infections by around 45%
7 Dec, 2020 | 00:46h | UTC
Randomized trial: High-dose influenza vaccine shows no additional benefit for heart disease patients
7 Dec, 2020 | 00:44h | UTCEditorial: Influenza Vaccine for Patients With High-risk Cardiovascular Disease
Commentary: High-dose influenza vaccine shows no additional benefit for heart disease patients – NIH News Releases
Commentary on Twitter
In patients w high-risk CVD, high-dose trivalent influenza vaccine, vs standard-dose quadrivalent vaccine, did not significantly reduce all-cause mortality or cardiopulmonary hospitalizations https://t.co/I3XygBajQL
— JAMA (@JAMA_current) December 4, 2020
Meta-analysis reinforces the safety of betablockers in patients with COPD and cardiovascular disease
6 Dec, 2020 | 23:30h | UTCCommentary: Beta-Blockers in Patients With COPD and CVD – American College of Cardiology
Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program
4 Dec, 2020 | 08:33h | UTCEditorial: Evolving Strategies for Long-term Asthma Management – JAMA
Commentaries: New Asthma Guidelines Published in The Journal of Allergy and Clinical Immunology, an Official Journal of the AAAAI – American Academy of Allergy, Asthma & Immunology AND New updates to federal guidelines revamp asthma management – NHLBI News
New WHO Guidance on masks for the public and health workers in the context of COVID-19
4 Dec, 2020 | 08:24h | UTCMask use in the context of COVID-19 – World Health Organization
Commentaries: WHO fine-tunes advice on COVID masks for public, health workers – Reuters AND WHO updates mask advice, recommending they be worn in indoor, poorly ventilated areas – CBC
Commentary on Twitter
.@WHO has tightened its guidance on face masks, recommending that where COVID-19 is spreading, masks be worn by everyone in healthcare settings, indoor low ventilated areas & outdoors when a distance of 3 ft from others cannot be maintained. #MaskUpAmerica https://t.co/dJUJ2syDMN
— IDSA (@IDSAInfo) December 3, 2020
Why the CDC changed its Covid-19 quarantine guidelines
4 Dec, 2020 | 08:18h | UTCWhy the CDC changed its Covid-19 quarantine guidelines – Vox
CDC Guideline: Duration of Isolation and Precautions for Adults with COVID-19 – Centers for Disease Control and Prevention
Moderna vaccine: Antibody levels persist for at least 4 months
4 Dec, 2020 | 08:16h | UTCDurability of Responses after SARS-CoV-2 mRNA-1273 Vaccination – New England Journal of Medicine
UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week
3 Dec, 2020 | 08:44h | UTCPress release: UK medicines regulator gives approval for first UK COVID-19 vaccine – Medicines and Healthcare products Regulatory Agency
See also: Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK – BBC AND Expert reaction to news that the MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for mass UK roll out – Science Media Centre AND UK approves Pfizer/BioNTech Covid vaccine for rollout next week – The Guardian
WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19
3 Dec, 2020 | 08:47h | UTCAudio Interview: Caring for Hospitalized Patients with Covid-19
Commentary on Twitter (thread – click for more)
The biggest multinational pandemic randomised trial #SOLIDARITYtrial published in the New England Journal of Medicine. https://t.co/VbpbpziFwm
WHO, trial leaders, numerous countries, hospitals, doctors, nurses, patients & many others are to be congratulated!
Key results ?? 1/5 pic.twitter.com/Xe9K6EfUpc
— Kari Tikkinen (@KariTikkinen) December 2, 2020
Review: Cytokine Storm
3 Dec, 2020 | 08:46h | UTCCytokine Storm – New England Journal of Medicine
Commentary on Twitter
Cytokine storm is a prominent feature in severe #COVID19. This new @NEJM review on it is as good as it gets. By @DavidFajgenbaum @carlhjune @PennMedicine https://t.co/a4qE7xGR58 pic.twitter.com/Ul1HrnL8Ve
— Eric Topol (@EricTopol) December 2, 2020
CDC to shorten COVID-19 quarantine to 10 days, 7 with test
3 Dec, 2020 | 08:40h | UTCCDC to shorten COVID-19 quarantine to 10 days, 7 with test – Associated Press
Commentary: CDC Shortens Its COVID-19 Quarantine Recommendations – NPR
Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer
2 Dec, 2020 | 07:31h | UTC
What’s the difference between viral shedding and reinfection with COVID-19?
2 Dec, 2020 | 07:29h | UTCWhat’s the difference between viral shedding and reinfection with COVID-19? – The Conversation
Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)”
2 Dec, 2020 | 07:19h | UTC
Commentary on Twitter
Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review https://t.co/lmWQNgpIfd Existing evidence supports the wide-held belief that the the risk of #SARSCoV2 transmission is lower outdoors (< 10%).
— Carlos del Rio (@CarlosdelRio7) December 1, 2020